Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Family phone program for Black teens with type 1 diabetes

Tests a phone-based family program for Black youth with type 1 diabetes.

Plain-language title generated from the registry record
Registry title: Family Intervention for Black Teens With Type 1 Diabetes

Key facts

Where
Detroit, Memphis, and Washington D.C., United StatesSee the 4 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 10 and 14 years old?

Source: NCT06275412, who can take part

Where in United States

  • Wayne PediatricsDetroit, United StatesTaking people
  • LeBonheur Children's HospitalMemphis, United StatesTaking people
  • University of Tennessee Health Science Center-MemphisMemphis, United StatesTaking people
  • Children's National HospitalWashington D.C., United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Wayne State University
Trial code
NCT06275412
Record updated
27 August 2026
Original description
The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).Read full original descriptionShow less

Family mHealth Intervention to Improve Health Outcomes in Black Youth With Type 1 Diabetes

The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).

Inclusion: Age: 10 years, 0 months - 14 years, 11 months; Diagnosed with Type 1 diabetes; Diagnosed for at least 6 months; Black; Primary caregiver willing to participate; Residence within 30 miles of a recruitment site; Caregiver ownership of an Internet-enabled device (cell phone, laptop or desktop computer, tablet, etc).

Exclusion: Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality); Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis); Inability to speak or read English; Child is in out-of-home placement.

ClinicalTrials.gov NCT06275412